Paper8025652
Expression of insulin-like growth factor II (IGF-II) in human hepatocellular carcinomas: an immunohistochemical study.
D'Errico A and 8 others. Pathol Int, 1994. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Expression of insulin-like growth factor II (IGF-II) in human hepatocellular carcinomas: an immunohistochemical study. Papers, record 8025652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8025652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Expression of insulin-like growth factor II (IGF-II) in human hepatocellular carcinomas: an immunohistochemical study.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Insulin-Like Growth Factor II | Major topic |
| Liver Diseases | Major topic |
| Liver Neoplasms | Major topic |
| Adult | |
| Hepatitis B | |
| Hepatitis B Surface Antigens | |
| Humans | |
| Immunoenzyme Techniques | |
| Liver |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42511915 | HBx-Associated Reactivation of the IGF2 Locus in Chronic HBV Infection and HBV-Related Hepatocarcinogenesis: Evidence Boundaries and Biomarker Implications. | Biomedicines | 2026 | https://conductscience.org/library/papers/42511915 | PubMed |
| 29707155 | Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas. | Oncotarget | 2018 | https://conductscience.org/library/papers/29707155 | PubMed |
| 25741453 | The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma. | Natl Sci Rev | 2014 | https://conductscience.org/library/papers/25741453 | PubMed |
| 24969538 | Characterization of the inflammatory microenvironment and identification of potential therapeutic targets in wilms tumors. | Transl Oncol | 2014 | https://conductscience.org/library/papers/24969538 | PubMed |
| 18350600 | Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma. | World J Gastroenterol | 2008 | https://conductscience.org/library/papers/18350600 | PubMed |
| 11819776 | Expression of insulin like growth factor II and its receptor in hepatocellular carcinogenesis. | World J Gastroenterol | 2001 | https://conductscience.org/library/papers/11819776 | PubMed |
| 10704474 | Hepatitis B virus biology. | Microbiol Mol Biol Rev | 2000 | https://conductscience.org/library/papers/10704474 | PubMed |
| 10459021 | Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1. | J Cell Biol | 1999 | https://conductscience.org/library/papers/10459021 | PubMed |
| 9155694 | Co-localisation of insulin-like growth factor II and the proliferation marker MIB1 in hepatocellular carcinoma cells. | J Clin Pathol | 1997 | https://conductscience.org/library/papers/9155694 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IGF2 | 3481 | PubTator's text mining | https://conductscience.org/library/genes/3481 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8025652
GET https://conductscience.org/api/papers/v1/8025652/authors